New Ebola vaccine and treatment trials are about to begin in West Africa, U.S. officials say. In roughly two weeks, a study of two vaccines in Liberia will begin enrolling health workers, burial teams and others at high risk of infection, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. About 27,000 people will get one of the vaccines or a placebo.
In about three weeks, doctors in Liberia also will begin testing the experimental drug ZMapp on infected patients. READ MORE OF THIS STORY